New opportunities for treatment and prevention of neurodegenerative diseases with PTP1B inhibitors

Future Med Chem. 2023 Aug;15(16):1443-1447. doi: 10.4155/fmc-2023-0187. Epub 2023 Aug 23.

Authors

Dominika Kołodziej¹, Łukasz Sobczak^{2

3}, Krzysztof Z Łączkowski¹

Affiliations

¹ Department of Chemical Technology and Pharmaceuticals, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, 85-089, Poland.
² Hospital Pharmacy, Municipal Hospital in Bydgoszcz, Bydgoszcz, 85-826, Poland.
³ Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, 85-067, Poland.

PMID: 37610866
DOI: 10.4155/fmc-2023-0187

No abstract available

Keywords: Alzheimer's disease; PTP1B; Parkinson's disease; amyotrophic lateral sclerosis; multiple sclerosis; neurodegenerative diseases.

MeSH terms

Alzheimer Disease*
Amyotrophic Lateral Sclerosis*
Humans
Neurodegenerative Diseases* / drug therapy
Neurodegenerative Diseases* / prevention & control
Parkinson Disease*